20 episodes

What's News brings you the biggest news of the day, from business and finance to global and political developments that move markets. Get caught up in minutes twice every weekday, then take a step back with our What’s News in Markets wrap-up on Saturday and our What’s News Sunday deep dive.

WSJ What’s News The Wall Street Journal

    • News

What's News brings you the biggest news of the day, from business and finance to global and political developments that move markets. Get caught up in minutes twice every weekday, then take a step back with our What’s News in Markets wrap-up on Saturday and our What’s News Sunday deep dive.

    Nvidia’s Hot New Clients Are Countries, Not Companies

    Nvidia’s Hot New Clients Are Countries, Not Companies

    A.M. Edition for June 12. We look at a new and fast-growing source of revenue for Nvidia as governments around the world pile into the artificial intelligence boom. The WSJ’s Sam Schechner and Asa Fitch explain what we mean by “sovereign AI” and who stands to benefit from countries’ race to control their AI destinies. Plus, the U.S. continues a diplomatic push for an Israel-Hamas cease-fire, but its ambitious plan to help deliver aid to Gaza is falling apart. And, McKinsey’s boss is tackling his next big consulting project: his own firm. Luke Vargas hosts.



    Sign up for the WSJ's free What's News newsletter.

    Learn more about your ad choices. Visit megaphone.fm/adchoices

    • 14 min
    How ‘Anti-Woke’ Shareholders Are Going After Corporate America

    How ‘Anti-Woke’ Shareholders Are Going After Corporate America

    P.M. Edition for June 11. Hunter Biden was found guilty on all charges in a felony gun case. WSJ Justice Department reporter Ryan Barber discusses the verdict. And “anti-woke” activists have set their sights on corporate boards. Corporate news reporter Theo Francis explains what's behind the strategy. Plus, Andrea Petersen explains why some scientists are concerned about a sunscreen ingredient in your food. Sabrina Siddiqui hosts.



    Sign up for the WSJ's free What's News newsletter.

    Learn more about your ad choices. Visit megaphone.fm/adchoices

    • 13 min
    ‘Degen’ Traders Take on Wall Street

    ‘Degen’ Traders Take on Wall Street

    A.M. Edition for June 11. Risky trades are roaring in popularity, driven by amateur investors piling into meme stocks and long-shot bets. The WSJ’s Hannah Miao says these self-proclaimed degenerate traders have Wall Street paying attention. Plus, derivatives regulator Christy Goldsmith Romero emerges as the White House’s top pick to head the FDIC. And, one prison in Brazil trades guard dogs for geese—with great success. Luke Vargas hosts.



    Sign up for the WSJ's free What's News newsletter.

    Learn more about your ad choices. Visit megaphone.fm/adchoices

    • 15 min
    Americans Hate Inflation. That’s Bad News for the Fed.

    Americans Hate Inflation. That’s Bad News for the Fed.

    P.M. Edition for June 10. Economists say higher inflation than the 2% the Federal Reserve is aiming for could help the Fed get out of possible downturns. But, as economics reporter Justin Lahart points out, inflation is unpopular among consumers. And Apple announces a software update that includes generative artificial intelligence. Plus, extreme weather is putting crops like olives, cocoa and grapes at risk. Reporter Jon Emont says that is raising prices for goods like olive oil, chocolate and wine. Alex Ossola hosts.



    Sign up for the WSJ's free What's News newsletter.

    Learn more about your ad choices. Visit megaphone.fm/adchoices

    • 13 min
    Europe Shifts to the Right

    Europe Shifts to the Right

    A.M. Edition for June 10. Nationalist parties make a strong showing in European Union elections, dealing a setback to leaders in France and Germany. The WSJ’s Laurence Norman says the results could influence the EU’s agenda on migration and the environment. Plus, Israeli Prime Minister Benjamin Netanayahu’s top rival quits the government over his handling of the war in Gaza. And activist investor Elliott takes a big stake in Southwest Airlines. Luke Vargas hosts.



    Sign up for the WSJ's free What's News newsletter.

    Learn more about your ad choices. Visit megaphone.fm/adchoices

    • 13 min
    Ozempic Economics: Your Questions Answered

    Ozempic Economics: Your Questions Answered

    GLP-1 drugs like Ozempic, Wegovy, Mounjaro and Zepbound have been revolutionary for weight loss. They’re also sparking big changes in many industries – from food to medicine. Wall Street Journal tech editor Bradley Olson – who himself took a GLP-1 drug – and audio reporter Jessica Mendoza have been documenting impacts of this new class of drugs in a series – “Trillion Dollar Shot” – for our sister podcast The Journal. They answer listener questions on how it’s transforming bodies, fortunes and industries. Luke Vargas hosts.



    Further Reading

    The Quest for Treatments to Keep Weight Off After Ozempic 

    Can Ozempic Maker Novo Nordisk Keep Up Its Momentum? 

    How Drugs Like Ozempic Are Changing What We Think About Weight Loss 

    Learn more about your ad choices. Visit megaphone.fm/adchoices

    • 13 min

Top Podcasts In News

What Next | Daily News and Analysis
Slate Podcasts
Global News Podcast
BBC World Service
The News Agents - USA
Global
The News Agents
Global
The Daily T
The Telegraph
Newshour
BBC World Service

You Might Also Like

WSJ Your Money Briefing
The Wall Street Journal
The Journal.
The Wall Street Journal & Gimlet
WSJ Minute Briefing
The Wall Street Journal
WSJ Tech News Briefing
The Wall Street Journal
WSJ’s The Future of Everything
The Wall Street Journal
WSJ's Take On the Week
The Wall Street Journal

More by The Wall Street Journal

The Journal.
The Wall Street Journal & Gimlet
WSJ Your Money Briefing
The Wall Street Journal
Instant Message
The Wall Street Journal
WSJ Secrets of Wealthy Women
The Wall Street Journal
WSJ’s The Future of Everything
The Wall Street Journal
Redefining Rivalries
WSJ. Custom Studios